Skip to main content
Guidance

AMR engagement guide: references

Published 3 September 2026

© Crown copyright 2026

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/engagement-guide-for-infection-and-antimicrobial-resistance-amr/amr-engagement-guide-references

  1. McNulty C, Read B, Quigley A, Verlander NQ, Lecky DM. ‘What the public in England know about antibiotic use and resistance in 2020: a face-to-face questionnaire survey’ BMJ Open 2022: volume 12, issue 4, article e055464
  2. Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A and others. ‘Understanding the mechanisms and drivers of antimicrobial resistance’ The Lancet 2016: volume 387, issue 10014, pages 176 to 187
  3. UK Health Security Agency (UKHSA), Veterinary Medicines Directorate, Animal and Plant Health Agency, Food Standards Agency (2023). ‘Third UK One Health report: joint report on antibiotic use, antibiotic sales and antibiotic resistance, 2019’
  4. World Health Organization, Global AMR R&D Hub (2024). ‘Progress in G7 countries in tackling the antibiotic pipeline crisis’
  5. Joubert M, Botes M. ‘Public communication of antimicrobial resistance: a decade of scholarship (2015 to 2024)’ Public Health 2025
  6. Scott-Dearing E, Carter V, Corley M, Mathew P, Darzi A. ‘Patient and public involvement and engagement to improve impact on antimicrobial resistance’ Nature Communications 2025: volume 16, issue 1, article 1022
  7. Colquhoun G, Afseth J, Fagan R, Thomson F, Ring N. ‘Patient and public understanding of antimicrobial resistance: a systematic review and meta-ethnography’ JAC-Antimicrobial Resistance 2024: volume 6, issue 4, article dlae117
  8. Krockow EM, Jenkins DR, Mkumbuzi S, Flusberg SJ, Tarrant C. ‘Why antimicrobial resistance messaging fails: qualitative insights interpreted through the elaboration likelihood model’ JAC-Antimicrobial Resistance 2025: volume 7, issue 4, article dlaf148
  9. UKHSA (2025). ‘English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2024 to 2025’
  10. Ayorinde A, Ghosh I, Ali I, Zahair I, Olarewaju O, Singh M and others. ‘Health inequalities in infectious diseases: a systematic overview of reviews’ BMJ Open 2023: volume 13, issue 4, article e067429
  11. Harvey EJ, De Brún C, Casale E, Finistrella V, Ashiru-Oredope D. ‘Influence of factors commonly known to be associated with health inequalities on antibiotic use in high-income countries: a systematic scoping review’ Journal of Antimicrobial Chemotherapy 2023: volume 78, issue 4, pages 861 to 870
  12. Zhong X, Ashiru-Oredope D, Pate A, Martin GP, Sharma A, Dark P and others. ‘Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study’ EClinicalMedicine 2024: volume 66, article 102321
  13. Jenks NP, Pardos de la Gandara M, D’Orazio BM, Correa da Rosa J, Kost RG, Khalida C and others. ‘Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York community health centers’ Travel Medicine and Infectious Disease 2016: volume 14, issue 6, pages 551 to 560
  14. Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G and others. ‘Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis’ The Lancet 2018: volume 391, issue 10117, pages 241 to 250
  15. Pini A, Stenbeck M, Galanis I, Kallberg H, Danis K, Tegnell A and others. ‘Socioeconomic disparities associated with 29 common infectious diseases in Sweden, 2005–14: an individually matched case-control study’ The Lancet Infectious Diseases 2019: volume 19, issue 2, pages 165 to 176
  16. WHO (2023). ‘13 critical interventions that support countries to address antimicrobial resistance in human health’
  17. Shutt AE, Ashiru-Oredope D, Price J, Padoveze MC, Shafiq N, Carter E and others. ‘The intersection of the social determinants of health and antimicrobial resistance in human populations: a systematic review’ BMJ Global Health 2025: volume 10, article e017389

Back to home page

Go back to the home page.

Back to top